<DOC>
	<DOCNO>NCT00568620</DOCNO>
	<brief_summary>In parallel increase prevalence obesity worldwide , type 2 diabetes mellitus ( T2DM ) reach epidemic proportion . Despite multitude available therapy , bariatric surgery ( e.g. , roux-en-Y gastric bypass ( GBP ) ) proven effective long term treatment modality morbid obesity . Moreover , majority T2DM patient undergo GBP experience normalization blood glucose able discontinue anti-diabetes medication soon procedure . The insulin resistant state commonly see non-diabetic obese subject also improve GBP . Evidence recent animal study suggest rapid return euglycemia see T2DM patient GBP might part result exclude duodenum flow nutrient . With use enteral feeding tube , hope good understand factor human gut may predispose obese individual development insulin resistance T2DM .</brief_summary>
	<brief_title>The Role Duodenum Pathogenesis Insulin Resistance Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<criteria>Inclusion criterion lean , healthy control subject : 1 . Fasting plasma glucose ( FPG ) &lt; 100 2 . Age 18 55 3 . BMI 18.5 24.9 kg/m2 4 . Stable weight prior 3 month Inclusion criterion prediabetic individual : 1 . Based American Diabetes Association criterion FPG &gt; 100 &lt; 126 2 . Age 18 55 3 . BMI 35 60 kg/m2 4 . Stable weight prior 3 month Inclusion criterion diabetic individual : 1 . Diagnosis type 2 diabetes mellitus ( T2DM ) &lt; 5 year 2 . Hemoglobin A1c &lt; 8 % 3 . Age 18 55 4 . BMI 35 60 kg/m2 5 . Stable weight prior 3 month Exclusion criterion study subject : 1 . Use following medication : Thiazolidinediones , dipeptidylpeptidase IV ( DPPIV ) inhibitor ( e.g. , sitagliptin ) , GLP1 analog ( e.g. , exenatide ) . 2 . Subjects T2DM unable maintain adequate glycemic control ( i.e. , fast blood glucose exceeds 250mg/dL two consecutive test ) temporarily discontinue oral diabetes medication study study physician determines insulin therapy would appropriate . 3 . Females positive pregnancy test 5 . Prior gastric , duodenal , proximal jejunal surgery pancreas resection 6 . Known malabsorptive disorder 7 . History cancer past 5 year 8 . Renal insufficiency define serum creatinine &gt; 1.5 mg/dl 9 . Hepatic enzyme elevation great twice upper limit normal 10 . Current use warfarin clopidogrel 11 . Intercurrent infection 12 . Contraindication nasogastric nasojejunal feeding tube ( e.g. , deviate nasal septum , prior upper gastrointestinal bleed , history easy bleeding ) 13 . Residence outside great Nashville , TN area</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>